News
OpenSecrets reports the pharma industry led lobbying in Q2 2025, spending $105.4 million, followed by Ballard Partners at $20 million.
From rising tariffs and stricter regulations to the increasing complexity of global sourcing, pharmaceutical importers are ...
4don MSN
Trump, pharma industry discuss boosting medicine spending abroad to cut US prices, sources say
The Trump administration has been talking to drugmakers about ways to raise prices of medicines in Europe and elsewhere in ...
14h
Legit.ng on MSNPharmaceutical Company Owned by Nigerian Billionaire Opens New Facility
May & Baker is expanding its pharmaceutical operations with a facility in Anambra State to boost local medication production ...
Trump’s main effort, which he cited on August 3, centers on getting drugmakers to offer the same price in the US as they do in Europe and other peer countries, the so-called “Most Favored Nation” ...
The credit crunch has increased cost pressures on the pharmaceutical industry, Capgemini suggests that part of its response could be to open up a dialogue about the wider healthcare agenda. These ...
The Canadian pharmaceutical industry is still waiting to learn about tariffs as high as 200 per cent on exports to the U.S.
BNP Secretary General Mirza Fakhrul Islam Alamgir has warned of a severe crisis in the pharmaceutical industry, alleging that ...
The U.S. pharmaceutical industry is highly dependent on the government in other ways as well, through patent protection, restrictions on imports of lower-priced drugs and limits on drug resales.
Beyond their public statements, Harvard's Sarpatwari said he expected the pharmaceutical industry to be aggressive in lobbying Congress and taking other measures to preserve the FDA approval process.
The global pharmaceutical industry is among the most profitable, driven by its ability to price to value, especially in the United States. High profits attract investors and generate money for ...
Blockchain will greatly modernize the pharmaceutical industry, and I believe it will become the best way to handle certain initiatives that relate to transparency, privacy and traceability. At its ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results